Neuroprogression: the hidden mechanism of depression
Open Access
- 1 October 2018
- journal article
- review article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 14, 2837-2845
Abstract
For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage.Keywords
This publication has 44 references indexed in Scilit:
- The Neural Plasticity Theory of Depression: Assessing the Roles of Adult Neurogenesis and PSA‐NCAM within the HippocampusNeural Plasticity, 2013
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depressionMolecular Psychiatry, 2012
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illnessProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Overview of the Genetics of Major Depressive DisorderCurrent Psychiatry Reports, 2010
- Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depressionBrain Structure and Function, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- The limbic systemIndian Journal of Psychiatry, 2007
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Affective disorders, antidepressant drugs and brain metabolismMolecular Psychiatry, 2003
- Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal BehaviorNeuropsychopharmacology, 1999